Tag: novo nordisk

May 2, 2026

Novo Nordisk Launches Weekly Type 2 Diabetes Treatment in Tunisia

April 17, 2026

Ozempic vs. Mounjaro: Which GLP-1 Drug Better Preserves Lean Muscle?

February 25, 2026

Novo Nordisk’s UBT251: Promising New Weight Loss Drug Shows 20% Weight Loss in Trial

February 3, 2026

Novo Nordisk Forecasts Sales & Profit Decline Amid Obesity Market Competition

January 24, 2026

Hong Kong Weight Loss Injections: No Prescription Needed

January 8, 2026

JPM 2026: More Deals, Happy CEOs

January 3, 2026

Wegovy Pill Price: Novo’s Weight Loss Strategy

November 18, 2025

Telehealth & GLP-1 Drugs: Partnering for Prescription Growth

November 5, 2025

Novo Nordisk Failure: European Stock Plummets

September 30, 2025

Novo Nordisk Athlone Redundancies – Job Cuts Announced

September 30, 2025

Novo Nordisk Cuts Staff at Irish Business

September 26, 2025

Trump Announces New Pharmaceutical Tariffs

August 30, 2025

Denmark Economy Cools: Impact of Single Company

August 16, 2025

Wegovy Approved for Live Disease Treatment – Novo Nordisk

August 4, 2025

Novo Nordisk Troubles: Ireland News & Analysis

July 20, 2025

Daniel Drucker: Ozempic’s Father on Drug Study, Not Sales